J Child Neurol. 2004;19(9):680-686. Alternative treatments to anticonvulsant medications should be considered in patients with tuberous sclerosis complex when seizures cannot be effectively ...

Tuberous sclerosis complex is associated with radiologically visible abnormalities of brain structure, principally tubers and subependymal nodules. We reviewed the literature on neuroimaging of ...

Tuberous sclerosis, also called tuberous sclerosis complex (TSC), is a rare genetic multisystem disorder characterized by the ...

The Tuberous Sclerosis Complex (TSC) Fellowship at UAB provides an opportunity for pediatric and adult neurologists with an interest in TSC clinical research and patient care to develop specialized ...

Marinus Pharmaceuticals (NASDAQ: MRNS) is a micro-cap pharmaceutical stock with multiple Wall Street analysts seeing ...

Tubular adenomas are small, noncancerous polyps that can form in your colon. Doctors often remove them during a colonoscopy because they can sometimes become cancerous. An adenoma is a type of ...

Multiple sclerosis (MS) is a chronic autoimmune disease where the immune system attacks the myelin sheath, a protective covering around nerves in the brain and spinal cord. This causes damage that ...

Oct. 2, 2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical ...

“His condition is called tuberous sclerosis complex,” said McMillan’s mom, Meri Frederick. “It is a chromosomal mutation. And they — children, adults — have tumors that grow within ...

Exercise can be a challenge for some people with multiple sclerosis (MS). Muscle weakness, numbness, and balance issues can make physical activity difficult. Still, exercise is important for ...

Familial ALS (FALS) runs in families. About 5% to 10% of people with amyotrophic lateral sclerosis have this type. Changes to a gene cause FALS. Parents pass the faulty gene to their children.

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today is hosting an Investor and Analyst Day ...